Saturday, October 31, 2026

Ripple On Bullish Momentum: 5.62% Up In The Last 6 Hours

ViaNews Editorial Team

December 22, 2020

Ripple On Bullish Momentum: 5.62% Up In The Last 6 Hours

Ripple is currently on bullish momentum. At 10:04 EST on Tue 22 Dec, Ripple is at $0.49 and up by 5.62% in the last 6 hours.

Ripple Range

Over the last six hours, Ripple's higher value was $0.49 and the lower value was $0.46.

Over the last twelve hours, Ripple's higher value was $0.49 and the lower value was $0.46.

In relation to Ripple's daily highs and lows, it's 6.217% up from its trailing 24-hour low of $0.46 and 7.811% down from its trailing 24-hour high of $0.53.

Concerning Ripple's yearly highs and lows, it's 324.5% up from its 52-week low and 36.38% down from its 52-week high.

Last days news about Ripple

Ripple to face SEC suit over XRP cryptocurrency. According to The Wall Street Journal on Tue Dec 22, "Ripple Inc. said it will defend itself against a lawsuit from the Securities and Exchange Commission that claims the company violated investor-protection laws when it sold a bitcoin-like digital asset called XRP.", "Ripple had a $10 billion valuation in its most recent funding round in 2019, and XRP is the third-largest cryptocurrency by market value."

Cryptocurrency firm ripple expects to be sued by the sec; XRP plunges. According to CNBC on Tue Dec 22, "Instead of providing a clear regulatory framework for crypto in the U.S., (SEC Chairman) Jay Clayton inexplicably decided to sue Ripple - leaving the actual legal work to the next Administration."", "Ripple, the fintech company best known for cryptocurrency XRP, has said it expects to be sued by the Securities and Exchange Commission over allegations that it violated investor protection laws."

Ripple says it faces SEC lawsuit as cryptocurrency XRP drops. According to Bloomberg Quint on Tue Dec 22, "The U.S. regulator has "inexplicably decided to sue Ripple," the firm's Chief Executive Officer Brad Garlinghouse said in an emailed statement. ", "XRP, the world's third-largest cryptocurrency, slumped after Ripple Labs Inc. said it faces a U.S. Securities and Exchange Commission lawsuit over its affiliated token."

News about Bitcoin

The CIO of a new crypto fund that has returned 220% to investors this year explains why Bitcoin topped $20,000 for the first time ever this week - and shares another digital currency set to become.... According to Business Insider on Sat Dec 19, ""Ethereum is more flexible than Bitcoin. ", "Bitcoin has surged into the stratosphere this year, but it is by no means the best-performing cryptocurrency."

Crypto FOMO makes even a 350% premium on Bitcoin look appealing. According to Bloomberg Quint on Sat Dec 19, "But as Bitcoin's 200% year-to-date rally attracts feverish attention and stokes fears of further missing out on the gains, demand for anything with a crypto wrapper is booming. ", "A rough back-of-the-envelope calculation suggests that at a 34% premium, investors are paying the equivalent of $30,522 if Bitcoin's price is $22,800 per coin. "

Elon Musk inquired on twitter about 'large' Bitcoin transactions after a crypto booster suggested he convert Tesla's balance sheet. According to Business Insider on Mon Dec 21, "Before the exchange with Saylor, he tweeted "Bitcoin is my safe word," but then followed up by saying, "Just kidding, who needs a safe word anyway!?"", "Following the Saylor conversation, Musk tweeted: "Bitcoin is almost as bs as fiat money," and then suggested to his followers he's a fan of Dogecoin, a parody cryptocurrency."

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com